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Aim: The purpose of this report is to store the information of the pre-planning and compare
this  data with the actual data of the procedure.
Background: Currently, intraoperative electron beam radiotherapy clinical practice lacks a
treatment planning system.
Materials and methods: The RADIANCE concept approaches treatment planning by providing
the  user with a navigation platform based on a three-dimensional imaging system in which
the  radiation oncologist can target the tumor and risk areas in different sections (axial,
coronal, sagittal), while a volume rendering engine displays a 3D image that is automatically
updated as we make any changes of the space. Finally, the user may select the parameters
of  the applicator, energy and dose of treatment to optimize the procedure. Six cases are
clinically described and illustrated.
Results: RADIANCE is a useful tool in planning IOERT. Tumor segmentation and risk areas
with minimal guide in the selection of parameters for the applicator. Complex locations
are  challenging, where the experience and skill of the radiation oncologist is necessary
to  optimize the process. New developments include imaging innovated uses. Intraopera-
tive  imaging will approach reality and allow real time, dosimetry estimations, stereotactic
recognition of patient and tumor bed position, will guide automatization of radiation beam
recognition and pre-robotic arrangements with linear accelerator movements.Conclusions: RADIANCE off
disciplinary approach to o
actual treatment radiothe
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1.  Background
Radiation therapy (RT) involves the use of ionizing radia-
tion for the treatment of malignant conditions. The main
aim of intraoperative electron radiotherapy is the irradia-
tion of the tumor bed avoiding critical organs involvement
during the surgical procedure. This procedure involves a com-
plex technique that combines surgery with radiation therapy
applied to patients with surgically accessible tumors. There-
fore, it involves a modiﬁed strategy of conventional radiation
therapy and surgery.1 Although treatment planning is essen-
tial in radiotherapy,2,3 the lack of planning tools inﬂuences
the development of IOERT. Oncologists and surgeons must
identify, during surgery, the risk areas and displace nonin-
volved organs. Both specialists must choose cone diameter,
bevel angle and energy of electrons according to their knowl-
edge, experience and the information obtained during the
procedure in real time, which is a limitation for objective mon-
itoring of variables such as toxicity and coverage of target
volume.1 The need to adjust the irradiation not only to the
tumor volume but also to the anatomy of each patient makes
the use of CT (computed tomography), MRI (magnetic reso-
nance imaging) and positron emission tomography–computed
tomography (PET/CT) indispensable for RT. Intraoperative
radiotherapy minimizes the toxicity and increases the ther-
apeutic index by mechanical displacement of mobile normal
tissues.4 RADIANCE is the only radiotherapy treatment plan-
ning system designed for IORT. The RADIANCE project is an
Fig. 1 – Intraoperative electron-beam radiation therapy planning
region and adjacent areas of risk, reconstruction of the tumorectiotherapy 1 9 ( 2 0 1 4 ) 239–245
initiative developed by GMV (privately owned technological
business group) with the participation of Hospital General
Universitario Gregorio Maran˜ón (HGUGM) and Consorcio Hos-
pitalario Provincial de Castellón (HPC). The main objective of
the project is to simulate the virtual position of the applicator
superimposed on a CT scan or MRI. New imaging develop-
ments do extend the beneﬁt of pre-, intra- and post-planning
in IOERT.5
2.  Aim
The purpose of this report is to store the information of the
pre-planning and even compare planning with the actual data
of the procedure.
3.  Materials  and  methods
RADIANCE facilitates the user to plan and simulate IOERT,
allowing the radiation oncologist to interact and decide with
the surgeon on different aspects during the procedure. The
workstation has the ability to work with a CT before surgery,
including tumor location, allowing the user to move through
the different sections (axial, coronal, sagittal), while a volumeupdated as we make any changes. The system allows a pre-
planning before surgery in order to improve the surgical
procedure, a real time planning during surgery in order to
 in breast cancer requires segmentations in the tumor
omy cavity and interposition of protection of the chest wall.
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Here are the steps for planning the IOERT:
 Navigation, segmentation and multi-planar reconstruction:  The
graphics engine of the station is provided with a developed
system of three-dimensional reconstruction and volume
rendering in real time, provided to the oncologist that rep-
resents different segmentations on the axial, coronal, and
sagittal axes. The program allows the rotation and the pos-
sibility to change the volume rendering. Unlike external
beam radiation therapy, the tumor is not the main objec-
tive of planning, as this will be removed during the surgical
procedure. Still, it should be segmented as it facilitates cor-
rect deﬁnition of the tumor bed region and/or area at risk
for residual tumor that will guide positioning of the appli-
cator to encompass the target. The risk organs that will
be displaced or manipulated during surgery should also be
taken into account. Finally, planning the treatment volume
includes the tumor bed, considered a high-risk area of tumor
recurrence and residual tumor, together with the anatomi-
cal structures left in the surgical post-resection space. Determination of surgical frame and applicator parameters: With
the tool that deﬁnes the surgical frame, we can approximate
the expected anatomical access during the surgical proce-
dure. This will optimize the position of the applicator in the
Fig. 2 – Rectal cancer patient, bootherapy 1 9 ( 2 0 1 4 ) 239–245 241
space, improving the representation process in three dimen-
sions and the geometrical and physical limitations of the
procedure. After deﬁning the parameters, the user can select
the best-suited applicator and orient the surgical frame in
relation to the patient’s anatomical position. The worksta-
tion has the ability to modify parameters such as diameter,
bevel angle and orientation in space depending on tumor
size and position and structures that must be protected.
- Simulation and optimization of treatment parameters: The IORT
optimization parameters allow the user to modify the geom-
etry of the applicator position and orientation depending
on the patient’s anatomy. After that, the user can select
the energy of the electrons, which will be represented by
a dose–volume histogram of the region of interest. The
parameters can be enhanced to provide the best coverage
of high-risk areas with an acceptable dose. Dose calcula-
tion can be carried out by superimposing measured data on
water phantoms or by using dose calculation algorithms,
which take into account the densities of the surrounding
tissue. The ﬁnal result has the ability to store information
in a database for comparisons between different users.
- Reporting: RADIANCE provides a document which includes
applicator parameters (energy, diameter, bevel angle, posi-
tion, and orientation), dose–volume and isodose curves and
linear accelerator conﬁguration and to capture 3D images
that the user generated during the pre-planning.
sted to the presacral space.
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4.  Results
The validity and usefulness of RADIANCE planning tools
for IORT was assessed in a comparative study conducted
with the participation of three radiation oncologists, one of
them with over twenty years of experience in IORT and two
with four years of experience. Fifteen cases based on the
most representative locations of IORT treatments were eval-
uated including: 3 breast cancers, 6 primary rectal cancers,
1 retroperitoneal sarcoma, 1 resectable pancreatic cancer, 2
rectal monotopic recurrences, 1 ovary monotopic recurrence
and 1 Ewing sarcoma.5 Examples of practice-based RADIANCE
operation require each user to perform a simulation based on
imaging tests before surgery, taking into account clinical his-
tory data. Next, some typical IOERT candidates are illustrated
and discussed.
- Breast cancer:  IOERT planning in breast cancer requires seg-
mentations in the tumor region and adjacent areas of risk,
reconstruction of the tumorectomy cavity and interposition
of protection of the chest wall (Fig. 1).
• Case 1 Early stage breast cancer: 65 years old, cT1N0M0,
luminal A adenocarcinoma, left breast upper-outer quad-
rant. Sentinel node biopsy negative. Plus tumorectomy
plus IOERT (5 cm diameter applicator, 10 MeV  electrons,
chest wall protection, 21 Gy). Deﬁnitive pathology: Well
differentiated adenocarcinoma, estrogen receptors 90%,
progesterone receptors 80%, cerb-2 negative, Ki67 70%.
Follow up at 32 months with no evidence of disease (Fig. 1).
Fig. 3 – Patient with a resected pancreatic tumor receivingiotherapy 1 9 ( 2 0 1 4 ) 239–245
- Rectal cancer:  In the planning of rectal cancer it is important6
that the tumor risk area segmentation includes the
mesorectum. The experience and knowledge of radiation
oncologist is decisive to delineate the target precisely and
simulate the surgical resection tentatively.
• Case 2 Primary rectal cancer: Female, 65 years old, diag-
nosis of locally advanced primary rectal cancer cT4N0M0.
Imaging characteristics 8.5 cm diameter with extension to
muscle piriformis and gluteus. Neoadjuvant chemoradi-
ation, posterior exenteration (R2 resection). IOERT (5 cm
diameter applicator, 15 MeV  electrons, 15 Gy). Restaging
ypT3N0M0. Follow up at 15 months with local control
(Fig. 2).
-  Retroperitoneal sarcoma: Although segmentation of the tar-
get in the treatment of sarcomas is challenging in IOERT
planning, a high consistency in deﬁning parameters such as
tumor volume, risk areas, treatment parameters and normal
tissues to be displaced is consistent for trained oncologist.
- Pancreatic cancer:  The segmentation performed by different
radiation oncologists or surgeons might be variable in terms
of deﬁning the tumor volume and the risk area.7,8
• Case 3 Resected adenocarcinoma of the pancreas: 57
years old. cT2N0M0 (head of the pancreas 3 cm maxi-
mal  dimension, no vascular invasion, endoprosthesis).
Treated with preoperative chemoradiation, restaging with
stable disease. Duodenopancreatectomy plus IOERT (cone
8 cm diameter applicator, 12.5 Gy, 10 MeV  electrons, sin-
gle ﬁeld). Pathologic restaging ypT2N0M0. Follow up no
evidence of disease at 28 months (Fig. 3).
 a boost to the retroperitoneal–retropancreatic space.
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 Rectal cancer monotopic recurrence:  In localized relapse a deﬁ-
nition of risk area needs to be consistent with the treatment
parameters. Difﬁculty can be seen in estimating extended
surgical resection margin and its relationship with the
tumor bed region.9
• Case 4 Recurrent rectal cancer: Post-anterior rectal
resection. 82 years old, male. Diagnosis of cT3N+ rectal
cancer 3 years ago. Pain, pre-sacral 5 cm diameter mass
with extension to the coccyx. Neoadjuvant chemoradi-
ation, posterior exenteration plus inferior sacrectomy
and IOERT (10 cm diameter applicator, 10 MeV electrons,
12.5 Gy, protection of centro-pelvic stitches by led). Status
at 28 months with local control and liver metastasis
(Fig. 4).
 Gastroesophageal tumor10:
• Case 5 Locally advanced adenocarcinoma of the gastro-
esophageal junction: 59 years old, male. Dysphagia,
cT3N1Mo. Neoadjuvant treatment with chemoradiation
(Cisplatin plus 5FU plus 45 Gy), programmed radical
surgery plus IOERT (inferior mediastinum, 8 cm applica-
tor, 6 MeV  electrons, 10 Gy, 2 ﬁelds inferior mediastinum
and celiac trunk). Restaging pathology ypT1N0M0. Follow
up with no evidence of disease at 37 months (Fig. 5).
Fig. 4 – Patient with a locally recurrent rectal cancer, rectherapy 1 9 ( 2 0 1 4 ) 239–245 243
- Ewing sarcoma: Bone resection is uncertain to be pre-
planned, because it requires an intuition of the surgical
body position determined to identify the surgical require-
ments for optimal approach. RADIANCE allows to position
the patient prone and supine.
• Case 6 Extremity soft tissue sarcoma: 35 years old
female. Soft tissue mass in the upper left extremity.
Imaging characteristics: 9 cm diameter, intracomparti-
mental, liposarcoma. Limb preserving radical surgery.
R0 resection. IOERT (12 cm diameter applicator, 10 MeV
electrons, 12.5 Gy, single ﬁeld). No neuron-vascular pro-
tection. External beam radiotherapy 50 Gy/5 weeks. At 45
months of follow up alive with no evidence of recurrence.
Moderate ﬁbrosis in the radiotherapy region (Fig. 6).
5.  Discussion
The development of effective tools for planning IOERT hasprocedure and the lack of standardization of these processes.1
In external radiation treatments, planning is a critical step
that uses standardized imaging studies to determine the
eiving a boost to the posterolateral pelvic sidewall.
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 juncFig. 5 – Patient with a gastroesophageal
volume and organs at risk. Planning in external radiotherapy
is far from perfect, but their limitations are well accepted
in practice. Establishing and consolidating an IOERT program
involves many  aspects from the institutional point of view as
it requires structural organization and human resources, such
as modiﬁed accelerators, multidisciplinary team, coordinated
action of surgeons, anesthetists, medical physicists, radiation
5oncologists, nurses.
The RADIANCE system offers users a supported learn-
ing curve, acquiring new skills and the ability to evaluate
combined cancer treatments, decision processes coordinated
Fig. 6 – Patient with an upper extremity soft tissue tion cancer receiving a two-ﬁeld boost.
with surgeons and to optimize the ﬁnal treatment. RADIANCE
can help address the needs of pre-planning and simulation
systems illustrated with real cases with positive results.
Images before surgery, showing variations in patient anatomy
during surgery requires to explore intraoperative imaging and
advanced models of dose for further technological improve-
ment. Developmental and innovative research projects
in imaging opportunities for IOERT have generated pilot
information in breast cancer, retroperitoneal and extremity
sarcoma. Patients required transportation to the CT scan
used for external radiotherapy simulation and the images
sarcoma, receiving a boost to the tumor cavity.
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e  are obtained with the IOERT applicator in place.5 The
reast cancer and the extremity sarcoma model proved to
e feasible and the images obtained allowed generating
ose distribution within a close to real-time situation. In the
etroperitoneal sarcoma case, the metallic surgical retractors
sed for deep-intra-abdominal exposure and displacement
f movable normal tissues generated imaging interferences
hat limited the ability to estimate the status of the tumor
ed region (presence or not of ﬂuid) and the cavity of dose-
istribution in the manipulated anatomy. Nevertheless, the
cene for improved IOERT treatment planning is to move to 3D
econstruction of the altered anatomy after resection, normal
issue displacement, tumor bed deﬁnition and applicator
ositioning. An additional development is the recognition
f patient positioning and tumor bed identiﬁcation using
arkers. RADIANCE planning will automatize a signiﬁcant
art of the IOERT decision-making process.5
Breast cancer represents a major indication for IOERT.
inor differences in the implementation of the process sub-
ect to user-related variations and intervention protocols of
ifferent hospitals might be addressed by pre- and intra-
lanning imaging evaluation.5
The requirements of rectal cancer are more  heteroge-
eous, reﬂecting the difﬁculty of planning. Schedules change
ccording to the protocol followed in each institution, with
arameters such as anal margin resection or surgical approach
eing more  conservative. Despite these differences a proper
imulation can be made with the planning system, seeking a
onsensus to determine the irradiation volume, segmentation
f risk areas and to establish the framework surgery. Applica-
or parameters from the comparison results between IOERT
ractitioners in expert institutions are similar, with minor
ariations in energy, cone diameter and bevel angle, which
s a high consistency in the process of standardization.
Regarding the rest of the illustrated cases, a lot of them
ntail individualized difﬁculty, nevertheless the results are
linically solid adapted variations regarding the position of the
pplicator, the energy, the diameter of the cone or the bevel
ngle.5
The lack of information about the surgical procedure and
he need to improve the relationship and communication
etween the RO and the surgical team is particularly evi-
ent with the incorporation of a treatment system into IOERT
ractice. Two aspects to consider strongly are the correct iden-
iﬁcation of risk areas and knowledge of the structures that are
5odiﬁed during the surgical procedure.
The future of this tool is to check and collect different
xperiences allowing users to adapt and improve the tools
vailable. RADIANCE offers a multidisciplinary approach andtherapy 1 9 ( 2 0 1 4 ) 239–245 245
an easy way to deﬁne and optimize treatment parameters
giving a real approximation of these treatment parameters.
Intraoperative imaging will maximize the potential of this
tool.
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